secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-06-01T23:13:20+00:00
Accession:  0001193125-26-251994
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73
--------------------------------------------------------------------------------

- Holder exercises 1,172,414 existing warrants at reduced $1.73/share for ~$2M cash gross proceeds.
- Company issues new warrant for up to 2,344,828 shares at $1.73, exercisable after stockholder approval, expiring May 29, 2028.
- Placement agent H.C. Wainwright receives warrants for 82,069 shares at $2.1625 per share.
- Company to file resale registration statement within 30 days; use best efforts to effect within 45 or 75 days.
- Existing warrants originally issued in November 2025 at $3.50 exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526251994/0001193125-26-251994-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526251994/d105562d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-251994

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer